Aesthetic Medcine World Congress - AMWC China
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Aesthetic Medcine World Congress - AMWC China — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
Aesthetic Medicine World Congress - AMWC China 2026
Dates: October 16–18, 2026
Location: Chengdu, China
About AMWC China
AMWC China is a premier global event in the field of aesthetic medicine, dedicated to advancing knowledge and fostering innovation. As part of the esteemed AMWC global series, this conference serves as a critical platform for exchanging cutting-edge technologies, scientific research, and industry best practices. The 6th edition of AMWC China will take place in Chengdu from October 16–18, 2026, featuring a combined conference and exhibition space spanning 11,000 square meters.
The event brings together top doctors, scientific researchers, and industry leaders worldwide to share the latest clinical experiences and research findings. By bridging China’s aesthetic medicine sector with the international community, AMWC China facilitates deep exchanges and integration of global technologies and concepts, driving industry growth and innovation.
Why Attend AMWC China?
- World-Class Program: Engage with a curated scientific agenda featuring groundbreaking research, interactive workshops, and expert-led sessions on the latest advancements in aesthetic medicine.
- Business Opportunities: Network with global industry players, explore partnerships, and access emerging markets in a dynamic environment designed to foster collaboration.
- Level Up Your Practice: Learn innovative techniques and practical insights from renowned speakers through hands-on training sessions to enhance your clinical expertise.
- Discovery First: Gain exclusive access to the newest products, technologies, and trends in aesthetic medicine, positioning you at the forefront of industry advancements.
Who Attends?
AMWC China attracts a diverse audience of professionals, including:
- Top doctors and clinicians
- Scientific researchers and academics
- Industry leaders and decision-makers
- Experts in anti-aging medicine, cosmetic surgery, dermatology, and related fields
- Global and domestic aesthetic medicine practitioners
Exhibition Highlights
The exhibition hall, spanning 11,000 square meters, is a global marketplace where attendees can explore the latest innovations in aesthetic medicine. It provides a hub for:
- Product demonstrations and launches
- Networking with exhibitors and sponsors
- Exploring partnerships and business development opportunities
Testimonials
"AMWC China is a significant event in the global medical aesthetics industry, combining professionalism and authority to effectively promote innovation in medical aesthetics technology and industry exchange."Dr. Lin GAO, Xi’an Honghui Hospital
"I wanted to express my heartfelt thanks for the incredible opportunity to be a speaker at AMWC. Participating in such a prestigious Chinese conference was a remarkable experience."Dr. Nino REISENER, M1 Med Beauty
"Everything was a wonderful experience in Chengdu, and the exchange of ideas and perspectives was inspiring."Xiaoning LI, Distinct HealthCare
Call to Action
Data sheet
Aesthetic Medicine World Congress - AMWC China – Event Attendee & Buyer Profile Analysis
Event date: October 16–18, 2026
Location: Chengdu, China
Event status: Upcoming
Research date: June 30, 2026
Event Overview
| Event Name | Aesthetic Medicine World Congress - AMWC China |
| Event Date | October 16–18, 2026 |
| Event Status | Upcoming |
| Venue | Venue not publicly confirmed in the provided official website text. |
| City | Chengdu |
| State / Region | Sichuan Province |
| Country | China |
| Organizer | Organizer name not publicly confirmed in the provided official website text. |
| Official Event Website | en.amwcchina.com |
| Event Type | Conference and exhibition |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness |
| Audience Reach | Global primary relevance with strong China market focus |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for attendee volume; confirmed for dates, city, country, and event positioning from official website text. |
| Main Purpose of Event | Scientific exchange, product discovery, clinical education, international industry networking, and aesthetic medicine business development. |
About the Event
AMWC China is the China edition of the global Aesthetic Medicine World Congress series and is positioned by the official website as a leading international event for aesthetic medicine, anti-aging technologies, clinical knowledge exchange, and innovation. The 6th edition is scheduled for October 16–18, 2026 in Chengdu, China, with an estimated combined conference and exhibition area of 11,000 square meters.
The event matters because it concentrates medical aesthetics decision-makers, doctors, scientific researchers, brands, and industry leaders in one commercial and educational setting. For suppliers, the event is relevant for buyer discovery, distributor conversations, practice-level procurement, product launch visibility, training-led engagement, and relationship building across China and international aesthetic medicine markets.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Aesthetic clinic owners and medical directors | Private aesthetic clinics, med-spa groups, medical beauty chains | Approve device purchases, injectables selection, treatment portfolio expansion, training budgets | High-value buyers for equipment, consumables, training, and practice growth solutions |
| Dermatologists and cosmetic physicians | Dermatology clinics, hospitals, aesthetic treatment centers | Strong clinical influence over treatment adoption and brand preference | Important for product trials, KOL advocacy, and repeat usage recommendations |
| Plastic surgeons and anti-aging specialists | Cosmetic surgery practices, specialty hospitals, anti-aging centers | Specify premium technologies, procedural products, and advanced service partnerships | High relevance for premium devices, implants, injectable platforms, and training |
| Hospital procurement and department managers | Public and private hospitals with dermatology, cosmetic surgery, or anti-aging units | Formal purchasing influence, vendor qualification, contract review | Relevant for institutional sales and regulated procurement pathways |
| Distributors and channel partners | Medical device distributors, aesthetic product importers, regional resellers | Evaluate portfolio additions, territory rights, and supplier partnerships | Critical for China market entry and regional market scaling |
| Brand and product leaders | Aesthetic device makers, filler brands, skincare companies, anti-aging solution providers | Influence go-to-market plans, competitive intelligence, launch timing | Useful for partnerships, white-label opportunities, and co-marketing |
| Scientific researchers and KOL speakers | Research institutes, teaching hospitals, expert clinics | Influence evidence-based adoption and peer trust | Important for clinical validation, trials, and education-led demand generation |
| Practice operations and business development leaders | Clinic groups, healthcare management firms, specialty operators | Assess ROI, operational efficiency, patient acquisition, vendor consolidation | Relevant for software, CRM, patient management, financing, and training services |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Chengdu | Local hospitals, clinics, distributors, and medical beauty operators | High | Host city concentration should support strong in-person attendance from western China healthcare and aesthetics markets. |
| Sichuan Province | Regional medical and aesthetic providers | High | Likely draw for clinics and hospitals seeking technology upgrades and supplier access. |
| Western China business hubs | Regional practice owners, distributors, and medical beauty groups | Medium to High | Chengdu acts as a major gateway for western China commercial and healthcare activity. |
| National China market | Doctors, researchers, brands, and industry leaders from across China | High | Official website positions the event as a bridge between China's aesthetics sector and the international market. |
| International | Global speakers, brands, scientific researchers, and industry leaders | Medium | Confirmed by official website language referencing global participation; exact country split not publicly confirmed. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website describes AMWC China as a leading global event and states it gathers top doctors, scientific researchers, and industry leaders from around the world, while also serving the China market. |
| National | Secondary reach description | Strong relevance across China's medical aesthetics ecosystem due to domestic-industry and international integration focus. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Xi’an Honghui Hospital | Hospital / clinical buyer organization | Official website includes testimonial from Lin Gao of Xi’an Honghui Hospital, indicating prior participation relevance from a hospital-based medical aesthetics stakeholder. | xahhyy.com | Director of Dermatology, Procurement Manager, Department Head, Medical Director | Prior-Year Participation Evidence |
| M1 Med Beauty | Aesthetic clinic / provider organization | Official website includes a testimonial from Dr. Nino Reisener of M1 Med Beauty describing participation as a speaker at AMWC, showing buyer and thought-leader relevance. | m1-beauty.com | Medical Director, Head of Aesthetics, Procurement Lead, Clinical Training Director | Prior-Year Participation Evidence |
| Distinct HealthCare | Healthcare provider / specialty clinic operator | Official website includes a testimonial from Xiaoning Li of Distinct HealthCare about AMWC China 2024, indicating prior engagement from a medical service organization. | distinctclinic.com | Clinic Director, Operations Director, Procurement Manager, Business Development Director | Prior-Year Participation Evidence |
| Current-year public attendee, buyer, or exhibitor organization lists were not included in the provided official website text. Prior-year participation evidence is not a confirmed attendee list for the current edition. | |||||
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director | Clinical Leadership | Director / Executive | Approves treatment protocols, technology adoption, and premium brand selection. |
| 2 | Clinic Owner / Founder | Executive Office | Owner / CXO | Direct budget authority for equipment, injectables, staffing, and expansion. |
| 3 | Procurement Manager | Procurement / Supply Chain | Manager | Manages vendor selection, pricing, contracts, and replenishment for consumables and devices. |
| 4 | Director of Dermatology / Cosmetic Medicine | Clinical Department | Director | Core evaluator of treatment efficacy, clinical safety, and patient demand. |
| 5 | Head of Plastic Surgery / Anti-Aging | Clinical Department | Director | Influences advanced procedural buying decisions and premium technology adoption. |
| 6 | Operations Director | Operations | Director | Evaluates ROI, patient throughput, workflow efficiency, and supplier performance. |
| 7 | Business Development Director | Business Development | Director | Useful for partnerships, new service lines, and market expansion deals. |
| 8 | Clinical Training Director | Medical Education | Director / Manager | Important when the offering requires physician certification, workshops, or procedural enablement. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Direct fit for hospitals, specialty clinics, and treatment centers attending for clinical and procurement reasons. | Institutional buyer targeting |
| 2 | Medical Devices | Core sector for energy-based devices, imaging, treatment systems, and procedural equipment. | Device manufacturer and distributor outreach |
| 3 | Pharmaceuticals | Relevant for injectables, toxins, therapeutics, and regulated anti-aging products. | Brand and medical affairs targeting |
| 4 | Biotechnology | Useful for regenerative aesthetics, anti-aging R&D, and innovation-driven clinical solutions. | Innovation and partnership outreach |
| 5 | Health, Wellness & Fitness | Applicable to anti-aging, wellness-led aesthetics, and premium consumer health positioning. | Wellness clinic and anti-aging center targeting |
| 6 | Cosmetics | Relevant for skincare, cosmeceuticals, post-procedure products, and premium treatment adjacencies. | Brand partnerships and clinic retail programs |
| 7 | Consumer Goods | Useful for premium beauty, skincare, and treatment-support product suppliers. | Commercial channel expansion |
| 8 | Import & Export | Supports cross-border brands and distributors bringing international technologies into China. | Channel and market-entry targeting |
| 9 | Wholesale | Relevant for regional distributors and stocking partners. | Distributor and reseller prospecting |
| 10 | Research | Useful for scientific researchers and evidence-generation stakeholders. | Clinical collaboration and KOL outreach |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No usable attendee number in provided official website text | Website counters showed placeholder values rather than verified attendance totals. |
| Exhibitor count | Not publicly confirmed in provided text | Unconfirmed | Provided official website excerpt | A sponsors list exists on the website navigation, but no count was supplied in the provided source text. |
| Buyer count | Not publicly confirmed | Unconfirmed | Provided official website excerpt | No official buyer-program or hosted-buyer volume stated in the supplied source text. |
| Speaker count | Not publicly confirmed in usable form | Unconfirmed | Provided official website excerpt | Counter area displayed placeholder values. |
| Sponsor count | Not publicly confirmed in provided text | Unconfirmed | Provided official website excerpt | Sponsors List page is referenced in navigation only. |
| Conference + exhibition area | 11,000 square meters | Estimated | Official website “Who We Are?” section | Official wording states “estimated combined conference and exhibition area of 11,000 square meters.” |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Aesthetic medicine technologies | Treatment differentiation and clinical results | Live demos, physician education, ROI discussions | Energy-based devices, injectables, imaging, consumables |
| Anti-aging solutions | Expand service lines and premium treatment menus | Clinical evidence sessions and therapy comparison conversations | Therapeutics, wellness-linked protocols, regenerative products |
| Clinical education | Skills enhancement and safe adoption of new procedures | Workshops, expert talks, certification pathways | Training platforms, advisory services, education partnerships |
| Product discovery | Find next-generation products before competitors | Booth meetings, new product launches, distributor scouting | Launch-ready products, samples, channel programs |
| International market integration | Access global concepts and China commercialization paths | Partner meetings, distribution discussions, regulatory exploration | Import partnerships, localization support, channel expansion services |
| Practice growth and operations | Increase patient volume and improve profitability | Management meetings with clinic groups and operators | Practice software, patient engagement tools, financing, staffing support |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for clinical buyers, aesthetic practice owners, distributors, and hospital departments. |
| Decision-maker availability | High | Official positioning emphasizes doctors, researchers, and industry leaders rather than general public attendance. |
| Data collection potential | Medium | Useful event for account identification, but public current-year attendee proof is limited in the supplied source material. |
| Apollo targeting potential | High | Clear industry and job-title targeting exists across clinics, hospitals, devices, injectables, distributors, and wellness providers. |
| Geographic targeting potential | High | Can segment by Chengdu, Sichuan, western China, broader China, and selected international aesthetics markets. |
| Best outreach approach | High | Use education-led outreach, product efficacy messaging, KOL references, and partnership/distribution angles. |
| Overall lead quality | High | Good event for premium healthcare and aesthetic medicine lead generation where the offer is clinically or commercially relevant. |
| Best use case | B2B attendee list building | Best used for named-account building, speaker/exhibitor mapping, channel partner discovery, and medical aesthetics buyer profiling. |
| Limitations / risks | Medium | Public current-year attendee and buyer confirmation is limited in the supplied official text, so list-building should distinguish confirmed participation from prospecting assumptions. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Health, Wellness & Fitness; Cosmetics; Import & Export; Wholesale; Research | Capture core event buyer groups and commercial partners |
| Departments | Operations; Purchasing; Business Development; Medical / Clinical; Education; Executive | Align outreach to procurement, clinical evaluation, and expansion decisions |
| Seniority | Owner; Founder; C-Level; VP; Director; Head; Manager | Prioritize budget holders and strong clinical influencers |
| Job titles | Medical Director; Clinic Director; Founder; Procurement Manager; Director of Dermatology; Head of Aesthetic Medicine; Plastic Surgery Director; Anti-Aging Director; Operations Director; Business Development Director; Clinical Training Director | Improve precision in aesthetic medicine account targeting |
| Geography | China; Sichuan; Chengdu; key tier-1 and tier-2 China healthcare and beauty hubs; selected international aesthetics markets | Prioritize local conversion and wider China scaling |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001+ | Cover independent clinics through large hospital systems and multi-site operators |
| Keywords | aesthetic medicine; medical aesthetics; anti-aging; dermatology; plastic surgery; cosmetic clinic; med spa; injectables; fillers; laser; skin rejuvenation | Surface niche-relevant accounts beyond broad healthcare lists |
| Technologies, if relevant | Search by treatment modalities or software stack where applicable | Useful for workflow, imaging, CRM, or device-enabled offerings |
| Revenue range | Mid-market to enterprise for hospitals and clinic groups; SMB for owner-led clinics | Balance fast-close clinic opportunities with larger institutional accounts |
| Company type | Private clinics; hospital systems; specialty providers; distributors; importers; manufacturers | Supports both direct sales and channel strategy |
Suggested Apollo Search Logic: ("aesthetic medicine" OR "medical aesthetics" OR dermatology OR "plastic surgery" OR "anti-aging" OR injectables OR fillers OR laser OR "skin rejuvenation") AND (China OR Chengdu OR Sichuan) AND (director OR head OR manager OR founder OR owner OR procurement OR operations OR medical).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| AMWC China Official Website | Official event website | Confirmed event name, Chengdu location, China country, October 16–18, 2026 dates, global positioning, 11,000 sqm estimated area, and audience profile language. | High |
| AMWC China Official Website – Testimonials / Page Content | Official event content | Verified named organizations appearing on site: Xi’an Honghui Hospital, M1 Med Beauty, Distinct HealthCare, used only as prior-year participation evidence rather than current-year attendee confirmation. | High |
| Provided official website text excerpt | Primary supplied source | Used as the source of truth where venue, organizer name, and attendee counts were not explicitly confirmed. | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Aesthetic Medcine World Congress - AMWC China — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds